Cargando…

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection

Azithromycin, a member of the macrolide family of antibiotics, is commonly used to treat respiratory bacterial infections. Nevertheless, multiple pharmacological effects of the drug have been revealed in several investigations. Conceivably, the immunomodulatory properties of azithromycin are among i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khezri, Mohammad Rafi, Zolbanin, Naime Majidi, Ghasemnejad-berenji, Morteza, Jafari, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127529/ https://www.ncbi.nlm.nih.gov/pubmed/34015317 http://dx.doi.org/10.1016/j.ejphar.2021.174191

Ejemplares similares

The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy
por: Khezri, Mohammad Rafi, et al.
Publicado: (2022)

Bmal1 and Gut-lung axis in SARS-CoV-2 infection: New insight into the effects of melatonin on COVID-19 patients?
por: Khezri, Mohammad Rafi, et al.
Publicado: (2023)

Potential Antioxidative, Anti‐inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection
por: Jafari, Abbas, et al.
Publicado: (2021)

Neurological effects of elevated levels of angiotensin II in COVID-19 patients
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Gut microbiota and circadian rhythm in Alzheimer’s disease pathophysiology: a review and hypothesis on their association
por: Khezri, Mohammad Rafi, et al.
Publicado: (2023)

Immunopharmacological perspective on zinc in SARS-CoV-2 infection
por: Asl, Sima Heydarzadeh, et al.
Publicado: (2021)

Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence
por: Khezri, Mohammad Rafi, et al.
Publicado: (2023)

Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation
por: Asemani, Yahya, et al.
Publicado: (2022)

Potential effects of icariin, the Epimedium-derived bioactive compound in the treatment of COVID‐19: a hypothesis
por: Khezri, Mohammad Rafi, et al.
Publicado: (2022)

Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine
por: Nikfarjam, Sepideh, et al.
Publicado: (2020)

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
por: Aslan, Anolin, et al.
Publicado: (2021)

Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID‐19
por: Ghasemnejad-Berenji, Morteza, et al.
Publicado: (2020)

The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application
por: Rezaie, Jafar, et al.
Publicado: (2021)

mTOR inhibition: a double-edged sword in patients with COVID-19?
por: Ghasemnejad-Berenji, Morteza
Publicado: (2021)

Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
por: Aslan, Cynthia, et al.
Publicado: (2021)

Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
por: Kiaie, Seyed Hossein, et al.
Publicado: (2022)

Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
por: Nazari-Khanamiri, Fereshteh, et al.
Publicado: (2023)

Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
por: Jafari, Reza, et al.
Publicado: (2019)

Beneficial effects of Cyclosporine A in combination with Nortriptyline on germ cell-specific apoptosis, oxidative stress and epididymal sperm qualities following testicular ischemia/reperfusion in rats: a comparative study
por: Yazdani, Iraj, et al.
Publicado: (2022)

Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells
por: Majidi Zolbanin, Naime, et al.
Publicado: (2018)

A Novel Effect of Acyclovir on Hair Growth in BALB/c Mice: A Promising Future for Finding a New Topical Drug for the Treatment of Hirsutism
por: Sameei, Soran, et al.
Publicado: (2020)

The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2
por: Vicente, Josefina, et al.
Publicado: (2023)

2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
por: Unal, Mehmet Altay, et al.
Publicado: (2021)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
por: Roshdy, Wael H., et al.
Publicado: (2020)

Rapamycin protects testes against germ cell apoptosis and oxidative stress induced by testicular ischemia-reperfusion
por: Ghasemnejad-berenji, Morteza, et al.
Publicado: (2017)

Development and optimization of buspirone oral osmotic pump tablet
por: Derakhshandeh, K., et al.
Publicado: (2014)

Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
por: Alkotaji, Myasar
Publicado: (2020)

Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021)

Antiviral and Immunomodulatory Drugs
por: Sykes, Jane E., et al.
Publicado: (2014)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
por: Fantini, Jacques, et al.
Publicado: (2020)

Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes
por: Chessa, Céline, et al.
Publicado: (2020)

How Antivirals Might be Linked to the Emergence of New Variants of SARS-CoV-2
por: Mehdizadeh, Ali Reza, et al.
Publicado: (2021)

Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host
por: Agrawal, Shivangi, et al.
Publicado: (2022)

Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury
por: Yan, Yujie, et al.
Publicado: (2023)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rha5nlvogqe1v0fe403tiju3qs